Double immunofluorescence analysis with anti-phospho-S6 (recognizing the phosphoS240/S244 sites) and anti-CB1 antibodies confirmed the selective overactivation of the mTORC1 pathway in FCD Type II but not FCD Type I samples (Figures 1A,B). The gene discussed is CNR1; the disease is isolated focal cortical dysplasia type II.